Filing Details

Accession Number:
0001171843-14-000307
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-23 07:33:04
Reporting Period:
2014-01-13
Filing Date:
2014-01-23
Accepted Time:
2014-01-23 07:33:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1365216 Sucampo Pharmaceuticals Inc. SCMP Pharmaceutical Preparations (2834) 133929237
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1383377 R Gayle Dolecek 4520 East West Hwy, 3Rd Floor
Bethesda MD 20814
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-01-13 9,066 $4.41 9,066 No 4 M Direct
Common Stock Disposition 2014-01-13 9,066 $9.21 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2014-01-13 9,066 $0.00 9,066 $4.41
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
323,634 2021-05-02 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the reporting person on June 13, 2013
  2. 5,000 exercisable 5/2/2012; 4,066 exercisable 5/2/2013